National Pension Service Has $233.91 Million Stock Holdings in Stryker Co. (NYSE:SYK)

National Pension Service lessened its stake in shares of Stryker Co. (NYSE:SYK) by 11.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 649,670 shares of the medical technology company’s stock after selling 83,866 shares during the period. National Pension Service owned about 0.17% of Stryker worth $233,914,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Dunhill Financial LLC boosted its holdings in shares of Stryker by 94.9% during the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 37 shares during the period. Centricity Wealth Management LLC acquired a new position in Stryker during the 4th quarter worth approximately $30,000. BankPlus Trust Department acquired a new stake in Stryker in the fourth quarter valued at approximately $33,000. Darwin Wealth Management LLC bought a new stake in shares of Stryker during the third quarter worth $36,000. Finally, Activest Wealth Management bought a new position in shares of Stryker in the 4th quarter valued at $36,000. Institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

SYK has been the subject of several research reports. JMP Securities reissued a “market perform” rating on shares of Stryker in a research note on Tuesday, February 18th. Barclays upped their price target on shares of Stryker from $418.00 to $443.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Robert W. Baird increased their price objective on Stryker from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. StockNews.com downgraded Stryker from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Argus set a $450.00 price objective on Stryker in a research note on Monday, February 3rd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $422.15.

Stryker Stock Performance

Shares of SYK opened at $390.57 on Wednesday. Stryker Co. has a 12-month low of $314.93 and a 12-month high of $406.19. The company has a market cap of $149.03 billion, a PE ratio of 50.33, a price-to-earnings-growth ratio of 2.93 and a beta of 0.96. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The stock has a 50-day moving average price of $378.78 and a 200-day moving average price of $370.22.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period in the previous year, the business posted $3.46 earnings per share. As a group, equities analysts forecast that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. Stryker’s payout ratio is 43.30%.

Insider Activity

In other news, Director Allan C. Golston sold 2,458 shares of the company’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the sale, the director now directly owns 14,895 shares in the company, valued at $5,705,827.65. This represents a 14.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.